Works citing this work

2 works

Work: BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency

1. Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone

   Muzaffar Kayumov, Jia Li, Azizbek Pardaev +9

   ArticlePARP inhibition in cancer therapyEuropean Journal of Medicinal Chemistry20222 citations

   ABIABI:AkademIndex/openalex/2026.other.075060

2. Molecular-biological characteristics of triple negative breast cancer

   N. E. Atakhanova, Dilbar Muradovna Almuradova, I. A. Dudina

   ArticleAdvanced Breast Cancer TherapiesRussian Journal of Biotherapy20180 citations

   ABIABI:AkademIndex/openalex/2018.article.000554